SOD1 and amyotrophic lateral sclerosis: The effects of treatment ranged from slowing of deterioration to even improvement.29 Therefore, by slowing down the progression rate in patients with SOD1-ALS, Saini and Chawla logically concluded in a comprehensive review of the literature that tofersen has the potential to break barriers in ALS therapy.30